Pauline De Bruyne
Overview
Explore the profile of Pauline De Bruyne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Awouters M, Vanuytsel T, De Bruyne P, van Hoeve K, Hoffman I
Acta Paediatr
. 2025 Jan;
PMID: 39840674
Aim: Nutritional measures often suffice for managing high-output ileostomy (HOI) in paediatric patients, but pharmacological treatment may be required to control ostomy output. This paper reviews the literature on the...
2.
Winter D, De Bruyne P, van der Woude J, Rizopoulos D, de Ridder L, Samsom J, et al.
J Pediatr Gastroenterol Nutr
. 2024 May;
79(1):62-75.
PMID: 38698646
Objectives: Paediatric and adult inflammatory bowel disease (pIBD, aIBD) patients may lose response to anti-tumour necrosis factor (TNF) treatment within the first year. Adult-extrapolated weight-based dosing is incorrect in children,...
3.
Awouters M, Vanuytsel T, Huysentruyt K, De Bruyne P, van Hoeve K, Hoffman I
Acta Paediatr
. 2024 Feb;
113(5):861-870.
PMID: 38389122
Aim: Paediatric patients with high-output ileostomies (HOI) face an elevated risk of complications. This study aimed to comprehensively review the existing literature and offer nutritional management recommendations for paediatric patients...
4.
Sandra L, Degraeuwe E, De Bruyne P, De Baere S, Croubels S, Van Bocxlaer J, et al.
Br J Clin Pharmacol
. 2023 Oct;
90(2):504-515.
PMID: 37864281
Aims: Lisinopril, an angiotensin-converting enzyme inhibitor, is a frequently prescribed antihypertensive drug in the paediatric population, while being used off-label under the age of 6 years in the USA and...
5.
Bosschaert C, Van Renterghem K, Van de Putte D, Matthyssens L, Velde S, De Bruyne P, et al.
JPGN Rep
. 2023 May;
3(4):e259.
PMID: 37168462
Button battery (BB) ingestion is a preventable pediatric health hazard with important morbidity and mortality due to complications. We present 3 pediatric patients with a complicated course after BB ingestion...
6.
Peeters E, De Bruyne P, Van Waas M, Escher J, Doukas M, Hendriks D, et al.
Lancet Infect Dis
. 2021 Aug;
21(9):1332.
PMID: 34450079
No abstract available.
7.
De Bruyne P, Verloo P, Van Hove J, de Hemptinne B, Velde S, Van Winckel M, et al.
Pediatr Transplant
. 2020 Dec;
25(6):e13943.
PMID: 33314525
Background: HHH syndrome is a rare autosomal recessive disorder of the urea cycle, caused by a deficient mitochondrial ornithine transporter. We report the first successful liver transplantation in HHH syndrome...
8.
Van Waas M, De Bruyne P, de Ridder L
Lancet Gastroenterol Hepatol
. 2020 Dec;
6(1):80.
PMID: 33308436
No abstract available.
9.
Dossche L, Michelet R, De Bruyne P, Van Herzeele C, Gasthuys E, Rittig S, et al.
Arch Dis Child
. 2020 Aug;
106(6):597-602.
PMID: 32737054
Objective: To study the pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of desmopressin (dDAVP) oral lyophilisate in children below the age of 8 years with special emphasis on age-related and size-related differences in...
10.
Verhelst S, De Bruyne P, Van Winckel M, Boussery K, Tommelein E
Eur J Pediatr
. 2019 Oct;
179(1):111-119.
PMID: 31659469
As children are unable to make health-related decisions themselves, parents play a central role in consultations with healthcare providers. Parents' perspectives are therefore the focus of this study. Our first...